Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Minimally Invasive Surgery for Spontaneous Deep Intracerebral Hemorrhage

NCT07710313 · Tam Anh Research Institute · Updated 30 Sept 2026

What is being tested
Minimally Invasive Surgery (MIS); Standard medical treatment (SMT)
For
Intracerebral Hemorrhage; Spontaneous Intracerebral Hemorrhage; Basal Ganglia Hemorrhage
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 300 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 Nov 2026, ends 31 Dec 2028. Registered 17 July 2026.
Results
None posted yet.

In the researchers' words

This observational cohort study evaluates the real-world effectiveness and safety of minimally invasive surgery (MIS) versus standard medical management in adults with spontaneous deep intracerebral hemorrhage. Patients presenting to Tam Anh General Hospital and People's Hospital 115 within 72 hours of hemorrhage onset will be enrolled and followed for 180 days. Clinical, radiological, and treatment-related variables will be collected, with primary outcome measures including survival and functional outcomes during follow-up period.
ClinicalTrials.gov, NCT07710313